(MENAFN- GlobeNewsWire - Nasdaq) San Francisco, CA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Java World Mag is issuing this follow-up report to provide additional factual and legal context regarding its ...

Abstract: Empowered by their remarkable advantages, graph neural networks (GNN) serve as potent tools for embedding graph-structured data and finding applications across various domains. Particularly, ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

New images of the interstellar object 3I/ATLAS have captured an astonishing, multi-jet structure, with vast plumes extending millions of kilometers into space. The discovery, observed by Frank ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Yellow Tail Tech’s Data Tech for Jobs program helps beginners and career changers break into in-demand IT infrastructure roles. Yellow Tail Tech’s Data Tech for Jobs program helps beginners and career ...

The last time I wrote about Recursion Pharmaceuticals (RXRX), it was with respect to a Seeking Alpha article entitled "Recursion: CDK7 Differentiation Is Initially Paying Off." With respect to this ...